InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.

MBX Capital is an early-stage venture capital firm based in Claymont, Delaware, specializing in investments in the deep health sector, focusing on healthcare and biotechnology startups. The firm targets visionary founders addressing public health challenges through innovative solutions.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
MBX Capital is an early-stage venture capital firm founded in 2021 and based in the United States. The organization focuses on investing in visionary founders within the deep health sector. MBX Capital invests in companies primarily in their first or second institutional rounds, typically before they reach a $50 million valuation. The firm generally invests between $1 million to $4 million, seeking at least 5% ownership in the companies. While most investments are in the United States, MBX Capital is open to opportunities globally. The firm is agnostic to sector, with a requirement that companies have a clear vision to make a deep health impact.
MBX Capital primarily invests in companies during their first or second institutional rounds, typically before they reach a $50 million valuation. The firm is agnostic to sector but emphasizes the importance of a clear vision for deep health impact. Investments generally range from $1 million to $4 million, with a target of acquiring at least 5% ownership in the companies.
MBX Capital adds value to its portfolio companies by providing strategic guidance, industry connections, and support in navigating the complexities of the healthcare landscape. The firm is committed to fostering innovation and growth in the deep health sector.
MBX Capital invests in companies during their pre-seed, seed, and Series A stages, typically before they reach a $50 million valuation. The firm seeks to acquire at least 5% ownership in its portfolio companies.
Founders can reach out to MBX Capital via email at team@mbxcapital.com. It is recommended to include a clear vision of how their company addresses chronic diseases and the innovative solutions they offer.
MBX Capital focuses specifically on deep health innovations that tackle the root causes of chronic diseases, particularly through environmental toxins and industrial exposures. This targeted approach sets them apart in the venture capital landscape.
While MBX Capital primarily focuses on the United States, it is open to global investment opportunities, seeking companies that align with its deep health investment thesis.
MBX Capital typically invests between $1 million and $4 million in its portfolio companies, with initial checks generally falling between $1 million and $2.5 million.
MBX Capital adds value by leveraging its expertise in deep health, providing strategic guidance, and facilitating connections within the healthcare ecosystem to support portfolio companies in achieving their goals.
Superscout Pro
Is this page right?Reviewed · How the research works